Piper Sandler: 'We Recommend Buying Adeptus Biotechnologies (ADPT) Ahead of Catalyst-Rich 2026' Mar 10, 2026 08:28AM
Adeptus Biotechnologies Corp. (ADPT) PT Raised to $21 at TD Cowen Feb 6, 2026 09:25AM
Adeptus Biotechnologies Corp. (ADPT) PT Raised to $22 at BTIG Feb 6, 2026 06:01AM
Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 9c Feb 5, 2026 04:21PM
Piper Sandler on Adeptus Biotechnologies (ADPT): 'Multiple MRD Drivers, Operational Efficiencies, and 2026 Execution' Jan 13, 2026 07:58AM


Jan 12, 2026 07:30AM Adaptive Biotechnologies reports 55% revenue growth in 2025
Dec 30, 2025 08:03AM Adaptive Biotechnologies subsidiary raises up to $15 million in series A
Dec 15, 2025 08:00AM Adaptive Biotechnologies signs two TCR licensing deals with Pfizer
Dec 15, 2025 07:58AM Piper Sandler on Adeptus Biotechnologies Corp. (ADPT): 'Long Case Is Strengthened by Competition'
Nov 5, 2025 05:08PM Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 23c
Oct 15, 2025 06:18AM Adeptus Biotechnologies Corp. (ADPT) PT Raised to $20 at Piper Sandler
Sep 30, 2025 06:18AM Guggenheim Starts Adeptus Biotechnologies Corp. (ADPT) at Buy
Aug 19, 2025 04:50AM BTIG Reiterates Buy Rating on Adeptus Biotechnologies Corp. (ADPT)
Aug 6, 2025 01:33PM Piper Sandler Calls Adeptus Biotechnologies (ADPT) 'A Top Pick', Lifts Stock PT
Aug 6, 2025 07:56AM Adeptus Biotechnologies Corp. (ADPT) PT Raised to $11 at Morgan Stanley
Aug 6, 2025 06:06AM Adeptus Biotechnologies Corp. (ADPT) PT Raised to $14 at BTIG
Aug 5, 2025 04:40PM Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 7c
Jun 18, 2025 09:28AM Craig-Hallum Starts Adeptus Biotechnologies Corp. (ADPT) at Buy
Jun 3, 2025 04:07PM Grindr (GRND) appoints Chad Cohen to Board
May 30, 2025 07:30AM Adaptive Biotechnologies (ADPT) Highlights New Data at 2025 ASCO and EHA 2025
May 2, 2025 05:34AM Adeptus Biotechnologies Corp. (ADPT) PT Raised to $11 at BTIG
May 1, 2025 05:00PM Adaptive Biotechnologies (ADPT) Tops Q1 EPS by 9c
Apr 8, 2025 08:09AM Adaptive Biotechnologies (ADPT) Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
Mar 21, 2025 04:30AM Goldman Sachs Upgrades Adeptus Biotechnologies Corp. (ADPT) to Buy
Mar 10, 2025 11:39AM TD Cowen: 'Top 10 Themes Coming Out of 45th Annual Health Care Conference'
Feb 13, 2025 06:54AM Adeptus Biotechnologies Corp. (ADPT) PT Raised to $12 at Scotiabank
Feb 11, 2025 04:37PM Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 2c, provides guidance
Jan 14, 2025 07:30AM Adaptive Biotechnologies (ADPT) and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
Dec 18, 2024 06:30AM Adeptus Biotechnologies Corp. (ADPT) PT Raised to $9 at BTIG
Nov 7, 2024 04:11PM Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 7c ; Offers Guidance
Nov 7, 2024 07:31AM Adaptive Biotechnologies (ADPT) Receives Expanded Medicare Coverage of clonoSEQ
Oct 15, 2024 05:53AM Goldman Sachs Assumes Adeptus Biotechnologies Corp. (ADPT) at Neutral
Sep 27, 2024 06:26AM Piper Sandler Reiterates Overweight Rating on Adeptus Biotechnologies Corp. (ADPT)
Aug 29, 2024 07:31AM Adaptive Biotechnologies (ADPT) Announces IVDR Certification for clonoSEQ in European Union
Aug 1, 2024 04:44PM Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 2c, updates guidance